GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sastasundar Ventures Ltd (NSE:SASTASUNDR) » Definitions » Debt-to-EBITDA

Sastasundar Ventures (NSE:SASTASUNDR) Debt-to-EBITDA : 0.00 (As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Sastasundar Ventures Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Sastasundar Ventures's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0 Mil. Sastasundar Ventures's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0 Mil. Sastasundar Ventures's annualized EBITDA for the quarter that ended in Dec. 2024 was ₹-1,510 Mil. Sastasundar Ventures's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Sastasundar Ventures's Debt-to-EBITDA or its related term are showing as below:

NSE:SASTASUNDR's Debt-to-EBITDA is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.42
* Ranked among companies with meaningful Debt-to-EBITDA only.

Sastasundar Ventures Debt-to-EBITDA Historical Data

The historical data trend for Sastasundar Ventures's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sastasundar Ventures Debt-to-EBITDA Chart

Sastasundar Ventures Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.15 -1.14 - -0.08 -0.19

Sastasundar Ventures Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.01 - - -

Competitive Comparison of Sastasundar Ventures's Debt-to-EBITDA

For the Pharmaceutical Retailers subindustry, Sastasundar Ventures's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sastasundar Ventures's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sastasundar Ventures's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Sastasundar Ventures's Debt-to-EBITDA falls into.


;
;

Sastasundar Ventures Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Sastasundar Ventures's Debt-to-EBITDA for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(10.175 + 28.653) / -203.513
=-0.19

Sastasundar Ventures's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0) / -1510.428
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2024) EBITDA data.


Sastasundar Ventures  (NSE:SASTASUNDR) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Sastasundar Ventures Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Sastasundar Ventures's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Sastasundar Ventures Business Description

Traded in Other Exchanges
Address
7 Abanindra Nath Thakur Sarani, Azimganj House, 2nd Floor, Kolkata, WB, IND, 700017
Sastasundar Ventures Ltd is a Core Investment Company. Through its subsidiaries, the company is focused on the business of digital network of healthcare and portfolio management services. Its business segments are; Financial Services, and Healthcare Network. The majority of its revenue is generated from the Healthcare Network segment which includes activities for pathology and marketing of healthcare and OTC products through e-commerce portal and diagnostic services which consist of pathological/radiological investigations. Geographically, the company operates only in India.

Sastasundar Ventures Headlines

No Headlines